secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001628280-25-025006
Event type: litigation
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CAFC affirms validity of AbCellera's microfluidic cell culture patent against Bruker challenge
--------------------------------------------------------------------------------

- Federal Circuit affirms PTAB decision upholding all claims of U.S. Patent No. 10,087,408.
- Patent covers microfluidic devices for culturing and selective recovery of cells.
- Bruker Cellular (formerly Berkeley Lights) challenged validity on anticipation/obviousness grounds; both PTAB and CAFC rejected arguments.
- Ongoing multi-patent infringement suit between AbCellera and Bruker pending in N.D. California.
- AbCellera CEO expects to prove infringement case against Bruker in district court.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000162828025025006/0001628280-25-025006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000162828025025006/abcl-20250512.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-025006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer